BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 712076)

  • 1. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
    Ruco LP; Meltzer MS; Rosenstreich DL
    J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation.
    Schlager SI; Meltzer MS
    J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
    Tagliabue A; Boraschi D; McCoy JL
    J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
    Meltzer MS; Ruco LP; Boraschi D; Nacy CA
    J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
    [No Abstract]   [Full Text] [Related]  

  • 11. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation for tumor cytotoxicity: regulatory mechanisms for induction and control of cytotoxic activity.
    Meltzer MS; Occhionero M; Ruco LP
    Fed Proc; 1982 Apr; 41(6):2198-205. PubMed ID: 7075791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
    Drysdale BE; Shin HS
    J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
    Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
    Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the effects of endotoxin on macrophage tumor cell killing.
    Weinberg JB; Chapman HA; Hibbs JB
    J Immunol; 1978 Jul; 121(1):72-80. PubMed ID: 27559
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
    Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.